Parsifal - Pilot Atazanavir-Raltegravir Switch In Hiv Infected Subjects with A Reduction of Quality of Life Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 9 years ago on Monday, December 15, 2014, according to the United State Patent & Trademark Office
Word Mark Parsifal - Pilot Atazanavir-Raltegravir Switch in Hiv Infected Subjects with a Reduction of Quality of Life
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77873429
Status Date Monday, December 15, 2014
Filing Date Monday, December 15, 2014
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
Trademarks Dept. - Room D33-05
P.O. Box 4000
Princeton NJ 08648-4000

Case File Statements

Disclaimer with Predetermined Text "Pilot Atazanavir-Raltegravir Switch in Hiv Infected Subjects with a Reduction of Quality of Life"
Goods & Services Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, November 20, 2009
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.